Longeveron® to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa

MIAMI, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, today announced that it will participate in the Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa taking place October 6-8, 2025 in Phoenix, Arizona.

Read more at globenewswire.com